Adeptus Health Inc. (NYSE:ADPT) Files An 8-K Regulation FD Disclosure

Adeptus Health Inc. (NYSE:ADPT) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure

Story continues below

As previously reported by Adeptus Health Inc. (the “Company”), on April19, 2017, the Company and its subsidiaries (such subsidiaries, together with the Company, the “Debtors”) filed voluntary petitions (collectively, the “Petitions” and, the cases thereby, the “Bankruptcy Cases”) with the United States Bankruptcy Court for the Northern District of Texas, Dallas Division (the “Bankruptcy Court”) for reorganization relief under chapter 11 of title 11 of the United States Code. The cases were consolidated for administrative purposes only under Case No.17-31432.

On September13, 2017, the Debtors filed a Third Amended Joint Plan of Reorganization to Chapter 11 of the Bankruptcy Code (the “Plan”) with the Bankruptcy Court which amends the second amended joint plan of reorganization that was filed by the Debtors with the Bankruptcy Court on August1, 2017 and previously disclosed and filed on the Current Report on Form8-K that was filed with the Securities and Exchange Commission on August2, 2017.

On September13, 2017, the Bankruptcy Court entered an order (the “Order”) scheduling a confirmation hearing for the Plan to commence on September26, 2017 at 9:30 a.m.(Central Time).

The Debtors recommend that holders of claims refer to the limitations, risk factors and qualifications included in the Plan with respect to the information contained therein. Information contained in the Plan is subject to change, whether as a result of amendments to the Plan, requirements by the Bankruptcy Court, actions of third parties, or otherwise.

There can be no assurance that the Debtors’ stakeholders will approve the Plan or that the Bankruptcy Court will confirm the Plan. The Debtors will emerge from Chapter 11 when a plan receives the requisite approval from holders of claims, the Bankruptcy Court enters an order confirming a plan, and certain conditions to the effectiveness of a plan, as stated therein, are satisfied. This Current Report on Form8-K is not intended to be, nor should it be construed as, a solicitation for a vote on the Plan.

The foregoing description of the Plan does not purport to be complete and is qualified in its entirety by reference to the Plan, a copy of which is filed herewith as Exhibit99.1 and is incorporated herein by reference.

Cautionary Statements Regarding Forward-Looking Statements

This Current Report on Form8-K contains forward-looking statements within the meaning of Section27A of the Securities Act of 1933, as amended, and Section21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Forward-looking statements involve a number of assumptions, risks and uncertainties that could cause actual results to differ materially. Any forward-looking statements herein are made as of the date of this filing, and the Company undertakes no duty to update or revise any such statements except as required by the federal securities laws. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”) from time to time and which are accessible on the SEC’s website at www.sec.gov, including in the section entitled “Risk Factors” in the Company’s Form10-K for the fiscal year ended December31, 2015 and its Form10-Q for the three and nine months ended September30, 2016. Among the factors that could cause future results to differ materially from those provided in this Current Report on Form8-K are: (i)the Company’s ability to obtain Bankruptcy Court approval with respect to motions in the Bankruptcy Cases, (ii)the ability of the Company and its subsidiaries to consummate the transactions contemplated by the Plan, (iii)the effects of the Company’s bankruptcy filing on the Company and on the interests of various constituents, (iv)Bankruptcy Court rulings in the Bankruptcy Cases and the outcome of the cases in general, (v)the length of time the Company will operate under the Bankruptcy Cases, (vi)risks associated with third party motions in the Bankruptcy Cases, which may interfere with the Company’s ability to consummate the transactions contemplated by the Plan, (vii)the potential adverse effects of the Bankruptcy Cases on the Company’s liquidity or results of operations, (viii)the ability to operate the Company’s business and consummate the transactions contemplated by the Plan, (ix)the transactions contemplated by the DIP Credit Agreement and the Plan being subject to closing conditions, which conditions may not be satisfied

for various reasons, including for reasons outside of the Company’s control; (x)increased legal costs to execute the Company’s reorganization, and other risks and uncertainties, (xi)the Company’s ability to maintain contracts, trade credit and other customer, joint venture partner and/or vendor relationships that are essential to the Company’s operations, and (xii)the Company’s ability to retain key executives and employees, and (xiii)the factors discussed in the section entitled “Risk Factors” in the Company’s Form10-K for the fiscal year ended December31, 2015 and its Form10-Q for the three and nine months ended September30, 2016.

The Company’s stockholders are cautioned that trading in shares of the Company’s ClassA common stock during the pendency of the Bankruptcy Cases is highly speculative and poses substantial risks. Trading prices for shares of the Company’s ClassA common stock may bear little or no relationship to the actual recovery, if any, by holders in the reorganization (who would receive no value under the Plan filed today). Accordingly, the Company urges extreme caution with respect to existing and future investments in its ClassA common stock.

Item 9.01 Financial Statements and Exhibits


Adeptus Health Inc. Exhibit
EX-99.1 2 a17-22074_1ex99d1.htm EX-99.1 Exhibit 99.1   UNITED STATES BANKRUPTCY COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION     §   In re: § Chapter 11   §   ADPT DFW HOLDINGS LLC,…
To view the full exhibit click here

About Adeptus Health Inc. (NYSE:ADPT)

Adeptus Health Inc. is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals. It owns or operates facilities located in the Houston, Dallas/Fort Worth, San Antonio and Austin, Texas markets; Colorado Springs and Denver, Colorado markets, and Phoenix, Arizona market. Its freestanding emergency room facilities typically range from 6,000 to 7,000 square feet. Each facility has 6 to 9 emergency exam rooms, which include over two high-acuity suites, one child-friendly pediatric room, and a specialized obstetrics/gynecology room. Its radiology suites have in-house diagnostic imaging technology, including computerized tomography (CT) scanners, digital x-rays and ultrasounds, with final reads from on-call radiologists.

An ad to help with our costs